Clinical Trial Update: Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) [Phase 1, Phase 2]

View source ↗

Summary

This is an update on an ongoing Phase 1/2 trial of low-dose cladribine (CdA) in combination with valproic acid for previously treated chronic lymphocytic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Cladribine (cladribine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: UNKNOWN